Literature DB >> 6871781

Atrial fibrillation following physostigmine.

A H Maister.   

Abstract

The side effects of physostigmine, a tertiary amine anticholinesterase agent commonly used to treat postanaesthetic depression caused by a large number of drugs, are thought to be fairly mild. A case is reported in which atrial fibrillation followed a total dose of 2 mg of this drug to a patient who was slow in recovering from a general anaesthetic. The arrhythmia was self-limiting and required no therapy. Indications and precautions for the use of physostigmine are discussed.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6871781     DOI： 10.1007/bf03007867

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN： 0008-2856


  5 in total

1.  Reversal of Innovar-induced postanesthetic somnolence and disorientation with physostigmine.

Authors:  A V Bidwai; L R Cornelius; T H Stanley
Journal:  Anesthesiology       Date:  1976-03       Impact factor: 7.892

2.  Reversal of postoperative reactions to scopolamine with physostigmine.

Authors:  R E Holzgrafe; J J Vondrell; S M Mintz
Journal:  Anesth Analg       Date:  1973 Nov-Dec       Impact factor: 5.108

Review 3.  Behavioral and electroencephalographic effects of atropine and related compounds.

Authors:  V G Longo
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

4.  Reversal of diazepam-induced postanesthetic somnolence with physostigmine.

Authors:  A V Bidwai; T H Stanley; C Rogers; E K Riet
Journal:  Anesthesiology       Date:  1979-09       Impact factor: 7.892

5.  Physostigmine reversal of postoperative somnolence.

Authors:  G E Hill; T H Stanley; C R Sentker
Journal:  Can Anaesth Soc J       Date:  1977-11
  5 in total
  1 in total

Review 1.  Adverse Effects of Physostigmine.

Authors:  Ann M Arens; Tom Kearney
Journal:  J Med Toxicol       Date:  2019-02-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.